Saengkaew Tansit, Jantarat Chutima, Nosoognoen Wichit, Supornsilchai Vichit
.
J Pediatr Endocrinol Metab. 2017 Aug 28;30(9):931-938. doi: 10.1515/jpem-2017-0172.
Several endocrine disruptors (including phthalates) are considered to be a cause of obesity. However, the current evidence has not conclusively established an association between phthalates and metabolic abnormalities, especially in children. The objective of the study was to evaluate the association between urinary phthalate metabolites and metabolic abnormalities in obese Thai children and adolescents.
This cross-sectional case-control study was conducted in participants aged 7-18 years and divided into two groups: normal weight and overweight/obesity. Spot urine concentrations of two phthalate metabolites (monomethyl phthalate [MMP] and mono-n-buthyl phthalate [MBP]) were measured by high performance liquid chromatography (HPLC). Anthropometric data, including weight, height, body mass index (BMI), waist circumference (WC), hip circumference (HC), waist-to-hip ratio (WHR) and waist-to-height ratio (WHTR), were measured and calculated. Fasting plasma glucose, insulin, HbA1c, lipid profiles and hepatic transaminase were analyzed, and insulin resistance indices were calculated.
One hundred and fifty-five participants were included. The median MMP level in the normal weight and the overweight/obesity groups were 0 (0, 459.83) and 0 (0, 1623.50) μg/g Cr, respectively (p=0.933). The median MBP level in the normal weight and the overweight/obesity groups were 233.6 (118.1, 633.62) and 206.94 (7.4, 427.7) μg/g Cr, respectively (p=0.083). After adjusting for age, gender and puberty, there was no correlation between MBP and all anthropometric data and metabolic profiles. Participants with hypertriglyceridemia had lower MBP levels than those with normal TG level. MMP levels were not significantly different between the participants with normal and abnormal weight of all metabolic parameters.
Participants with hypertriglyceridemia had lower MBP levels than those with normotriglyceridemia. However, it cannot show the correlation between phthalate and metabolic parameters.
几种内分泌干扰物(包括邻苯二甲酸盐)被认为是肥胖的一个成因。然而,目前的证据尚未确凿地证实邻苯二甲酸盐与代谢异常之间的关联,尤其是在儿童中。本研究的目的是评估泰国肥胖儿童和青少年尿中邻苯二甲酸酯代谢物与代谢异常之间的关联。
这项横断面病例对照研究在7至18岁的参与者中进行,分为两组:正常体重组和超重/肥胖组。通过高效液相色谱法(HPLC)测量两种邻苯二甲酸酯代谢物(单甲基邻苯二甲酸酯[MMP]和单正丁基邻苯二甲酸酯[MBP])的即时尿浓度。测量并计算人体测量数据,包括体重、身高、体重指数(BMI)、腰围(WC)、臀围(HC)、腰臀比(WHR)和腰高比(WHTR)。分析空腹血糖、胰岛素、糖化血红蛋白、血脂谱和肝转氨酶,并计算胰岛素抵抗指数。
共纳入155名参与者。正常体重组和超重/肥胖组的MMP中位数水平分别为0(0,459.83)和0(0,1623.50)μg/g肌酐(p = 0.933)。正常体重组和超重/肥胖组的MBP中位数水平分别为233.6(118.1,633.62)和206.94(7.4,427.7)μg/g肌酐(p = 0.083)。在调整年龄、性别和青春期后,MBP与所有人体测量数据和代谢指标之间无相关性。高甘油三酯血症参与者MBP水平低于甘油三酯水平正常者。所有代谢参数体重正常和异常的参与者之间MMP水平无显著差异。
高甘油三酯血症参与者的MBP水平低于正常甘油三酯血症者。然而,这无法显示邻苯二甲酸盐与代谢参数之间的相关性。